HuGE Navigator|HuGE Literature Finder|PHGKB

HuGE Literature Finder

Records 1 - 4

Query Trace: Hyperplasia and JAK2[original query]

Clinicopathologic spectrum of myeloid neoplasms with concurrent myeloproliferative neoplasm driver mutations and SRSF2 mutations. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 Jun . Tashakori Mehrnoosh, Khoury Joseph D, Routbort Mark J, Patel Keyur P, Wang Sa A, Ok Chi Young, El-Hussein Siba, Kanagal-Shamanna Rashmi, Luthra Rajyalakshmi, Hu Shimin, Lin Pei, Pemmaraju Naveen, Bose Prithviraj, Verstovsek Srdan, Bueso-Ramos Carlos E, Medeiros L Jeffrey, Loghavi San Similar articles in PubMed
Evaluation of clinical and laboratory findings with JAK2 V617F mutation as an independent variable in essential thrombocytosis. Molecular biology reports 2014 Oct 41 (10): 6737-42. Cetin Güven, Ozkan Tuba, Turgut Seda, Ali Cikrikcioglu M, Cem Ar M, Ayer Mesut, Unlu Ayhan, Celik Sevda Rabia, Sekin Yahya, Karatoprak Cuma Similar articles in PubMed
Impact of JAK2 V617F mutation on hemogram variation in patients with non-reactive elevated platelet counts. PloS one 2013 8 (2): e57856. Zhou Juan, Ye Yuanxin, Zeng Shugen, Zhou Yi, Mao Zhigang, Song Xingbo, Ying Binwu, Lu Xiaojun, Jiang Hong, Wang Lanl Similar articles in PubMed
JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia. Journal of clinical pathology 2009 Sep 62 (9): 798-801. Pich A, Riera L, Sismondi F, Godio L, Davico Bonino L, Marmont F, Francia di Celle Similar articles in PubMed